Genetic Selection For High Acute Inflammatory Response Confers Resistance To Lung Carcinogenesis In The Mouse

REFERENCES

• Manenti G, Nomoto T, De Gregorio L, Gariboldi M, Stefania F, Nagao M, Dragani TA: Predisposition to lung tumorigenesis. Toxicol Lett. 2000;113:257–263
   Google Scholar
• Budillon A. Molecular genetics of cancer: oncogenes and tumor suppressor genes Cancer. 1995;76:1869–1873
   Google Scholar
• Perera FP: Molecular epidemiology: insights into cancer susceptibility risk assessment and prevention. J Natl Cancer Inst. 1996;88:496–509.
   PubMed Web of Science ®Google Scholar
• Lozupone F, Luciani F, Venditti M, Rivioltini L, Pupa S, Parmiani G, Belardelli F, Fais S: Murine granulocytes control human tumor growth in SCID mice. Int J Cancer. 2000;87:569–573. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Fioretti F, Fradelizi D, Stoppacciaro A, Ramponi S, Minty A, Sozzani S, Garlanda C, Vecchi A, Mantovani A: Reduced tumorigenicity and augmented leukocyte infiltration after monocyte chemotatic protein-3 (MPC-3) gene transfer: perivascular accumulation of dendritic cells in peritumoral tissue and neutrophil recruitment within the tumor. J Immunol. 1998;161:342–346.
   PubMed Web of Science ®Google Scholar
• Hevin MB, Friguet B, Fauve RM: Inflammation and anti-tumor resistance. V. Production of a cytostatic factor following cooperation of elicited polymorphonuclear leukocytes and macrophages. Int J Cancer. 1990;46:533–538.
   PubMed Web of Science ®Google Scholar
• Soiffer R, Lynch T, Mihm M, Jung K, Rhuda C, Schmollinger JC, Hodi FS, Liebster L, Lam P, et al: Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent anti-tumor immunity in patients with metastatic melanoma. Proc Natl Acad Sci U S A. 1998;22:13141–13146. [CROSSREF]
   Google Scholar
• O'Byrne KJ, Dalgleish AG: Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer. 2001;85:473–483. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Albina JE, Reichner JS: Role of nitric oxide in mediation of macrophage cytotoxicity and apoptosis. Cancer Metastasic Rev. 1998;17:39–53. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Moore RJ, Owens DM, Stamp G, Arnott C, Burke F, East N, Holdsworth H, Turner L, Rollins B, Paspaeakis M, Kollias G, Balkwill F: Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat Med. 1999;5:5828–831.
   Google Scholar
• Shacter E, Weitzman SA: Chronic inflammation and cancer. Oncology. 2002;16:217–226.
   PubMed Web of Science ®Google Scholar
• Ibanez OM, Stiffel C, Ribeiro OG, Cabrera WK, Massa S, De Franco M, Sant'Anna OA Decreusefond C, Mouton D, Siqueira M, Biozzi G: Genetics of nonspecific immunity: I.Bidirectional selective breeding of lines of mice endowed with maximal or minimal inflammatory responsiveness. Eur J Immunol. 1992;22:2555–2563. [CSA]
   PubMed Web of Science ®Google Scholar
• Ribeiro OG, Maria DA, Adriouch S, Pechberty S, Ibañez OM, Seman M: Convergent alteration of granulopoiesis, chemotatic activity and neutrophil apoptosis in mice genetically selected for high acute inflammatory response. J Leuk Biol. 2003;74:497–506. [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Araújo LMM Ribeiro OG, Siqueira M, De Franco M, Massa S, Cabrera WHK, Mouton D, Seman M, Ibañez OM: Innate resistance to infections by intracellular bacteria differs in mice selected for maximal or minimal acute inflammatory reactivity. Eur J Immunol. 1998;28:2913–2920. [CSA]
   PubMed Web of Science ®Google Scholar
• Vigar ND, Cabrera WK, Araujo LM, Ribeiro OG, Ogata TP, Siqueira M, Ibañez OM, De Franco M: Pristane-induced arthritis in mice selected for maximal or minimal acute inflammatory reaction. Eur J Immunol. 2000;30:431–437. [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Biozzi G, Ribeiro OG, Saran A, Araujo LMM, Maria DA, De Franco M, Cabrera WHK, Sant'Anna OA Massa S, Pioli C, Doria G, Decreusefond C, Mouton D, Siqueira M, Ibañez OM: Effect of genetic modification of acute inflammatory responsiveness on tumorigenesis in the mouse. Carcinogenesis. 1998;19:337–346. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Maria DA, Ribeiro OG, Pizzocaro K, De Franco M, Cabrera WK, Starobinas N, Gallois V, Siqueira M, Seman M, Ibañez OM: Resistance to melanoma metastases in mice selected for high acute inflammatory response. Carcinogenesis. 2001;22:337–342. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Maria DA, Manenti G, Galbiati F, Ribeiro OG, Cabrera WK, Barrera RG, Pettinicchio A, De Franco M, Starobinas N, Siqueira M, Dragani TA, Ibañez OM: Pulmonary adenoma susceptibility (Pas 1) locus affects inflammatory response. Oncogene. 2003;22:426–432. [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Dragani TA, Manenti G, Pierotti MA: Genetics of murine lung tumors. Adv Cancer Res. 1995;67:83–112. [CSA]
   PubMed Web of Science ®Google Scholar
• Manenti G, Stafford A, De Gregorio L, Gariboldi M, Falvella FS, Avner P, Dragani TA: Linkage disequilibrium and physical mapping of Pas1 in mice. Genome Res. 1999;9:639–646. [CSA]
   PubMed Web of Science ®Google Scholar
• Giardiello FM, Offerhans GJ, Dubois RN: The role of nonsteroidal anti-inflammatory drugs in colorectal cancer. Eur J Cancer. 1995;31:1071–1076. [CROSSREF]
   Google Scholar
• Castonguay A, Duperron C: Chemo-preventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice. Carcinogenesis. 1997;18:1001–1006. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Rosenberg DW, Liu Y: Induction of aberrant crypts in murine colon with varying sensitivity to colon carcinogenesis. Cancer Lett. 1995;92:209–214. [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Malkinson AM, Radcliffe RA, Bauer AK: Quantitative trait locus mapping of susceptibilities to butylated hydroxytoluene-induced lung tumor promotion and pulmonary inflammation in CXB mice. Carcinogenesis. 2002;23:411–417. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Qin Z, Kim HJ, Hemme J, Blankenstein T: Inhibition of methylcholanthrene-induced carcinogenesis by an interferon gamma receptor-dependent foreign body reaction. J Exp Med. 2002;195:1479–1490. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Clish CB, Gronert K, Serhan CN: Local and systemic delivery of an aspirin-triggered lipoxin stable analog inhibits neutrophil trafficking. Ann N Y Acad. 2000;905:274–278. [CSA]
   PubMed Web of Science ®Google Scholar
• Stanford SJ, Pepper JR: Release of GM-CSF and G-CSF by human arterial and venous smooth muscle cells: differential regulation by COX-2. Br J Pharmacol. 2000;129:835–838. [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Bol DK, Rowley B, Ho C, Pilz B, Dell D, Swerdel M, Kiguchi K, Muga S, Klein R, Fischer SM: Cyclooxygenase-2 overexpression in the skin of transgenic mice results in suppression of tumor development. Cancer Res. 2002;62:2516–2521.
   PubMed Web of Science ®Google Scholar
• Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, Willoughby DA: Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med. 1999;6:621–622.
   Google Scholar
• Yao R, Rioux N, Castonguay A, You M: Inhibition of COX-2 and induction of apoptosis: two determinants of nonsteroidal ant-inflammatory drugs chemopreventive efficacies in mouse lung tumorigenesis. Exp Lung Res. 2000;26:731–742. [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Berman KS, Verma UN, Harburg G, Minna JD, Cobb MH, Gaynor RB: Sulindac enhances tumor necrosis factor-α-mediated apoptosis of lung cancer cells lines by inhibition of nuclear factor-κB. Clin Cancer Res. 2002;8:354–360. [CSA]
   PubMed Web of Science ®Google Scholar
• Bauer AK, Dwyer-Nield LD, Malkinson AM: High cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) contents in mouse lung tumors. Carcinogenesis. 2000;21:543–550. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Leung KH, Ip MM, Koren HS: Regulation of human natural killing. IV. Role of lipoxygenase in regulation of natural killing activity. Scand J Immunol. 1986;24:371–380.
   PubMed Web of Science ®Google Scholar
• Voth R, Chmielarczyk W, Storch E, Kirchner H: Induction of natural killer cell activity in mice by injection of indomethacin. Nat Immuno Cell Growth Regul. 1986;5:317–324.
   PubMedGoogle Scholar
• Gorelik E, Herberman RB: Susceptibility of various strains of mice to urethane-induced lung tumors and depressed natural killer cell activity. J Natl Cancer Inst. 1981;67:1317–1322.
   PubMed Web of Science ®Google Scholar
• Allen JW, Stoner GD, Pereira MA, Backer LC, Sharief Y, Hatch GG, Campbell JA, Stead AG, Nesnow S: Tumorigenesis and genotoxicity of ethyl carbamate and vinyl carbamate in rodent cells. Cancer Res. 1986;46:4911–4915.
   PubMed Web of Science ®Google Scholar
• Castonguay A, Rioux N, Duperron C, Jalbert G: Inhibition of lung tumorigenesis by NSAIDS: a working hypothesis. Exp Lung Res. 1998;24:605–615. [CSA]
   PubMed Web of Science ®Google Scholar
• Dragani T: 10 years of mouse cancer modifier loci: human relevance. Cancer Res. 2003;63:3011–3018.
   PubMed Web of Science ®Google Scholar
• Demant P.: Cancer susceptibility in the mouse: genetics biology and implications for human cancer. Nat Rev/Genet. 2003;4:721–735. [CROSSREF]
   Google Scholar